PHARMACY

National Pharmaceutical Council names Paul VP of clinical, scientific affairs

BY Alaric DeArment

RESTON, Va. The National Pharmaceutical Council has appointed a new VP for clinical and scientific affairs.

The organization announced Monday that it had appointed Les Paul, who will coordinate NPC’s strategic focus on evidence-based medicine for healthcare decision making, helping to facilitate dialogue between the pharmaceutical industry and stakeholders.

“Dr. Paul’s experience within the pharmaceutical industry, as well as his work in managed care and as practicing physician are real assets for NPC and make him uniquely qualified to lead our new focus on evidence-based medicine,” NPC president Dan Leonard said in a statement.

Paul, who has more than 25 years of experience in health care, previously served as vice president for United States medical affairs at Novartis. He also served for three years as vice president for medical affairs at AstraZeneca.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

CVS Caremark expands H1N1 vaccinations to more locations

BY Antoinette Alexander

WOONSOCKET, R.I. CVS Caremark is now providing H1N1 flu vaccinations at select CVS/pharmacy locations in Alabama, Illinois, Kansas, Missouri, Pennsylvania and New York, as well at MinuteClinic locations in Massachusetts and Connecticut.

The eight states are among many that have lifted priority group restrictions, allowing all patients to be eligible to receive the shot while supplies last.

“Our customers depend on CVS/pharmacy and MinuteClinic for their health care needs, so we are pleased to be able to expand H1N1 vaccine availability to these additional states,” stated Troyen A. Brennan, M.D., chief medical officer of CVS Caremark. “H1N1 flu is currently active in many communities across the country and it is likely that we will see increased flu activity, as is typically the case, in January and February.”

CVS Caremark continues to expand the availability of H1N1 vaccine in its stores and retail health clinics across the country and the vaccine now is available in 28 states and Washington, DC at either CVS/pharmacy or at MinuteClinic.

H1N1 vaccine is being offered at:

  • Select CVS/pharmacy locations in Alabama, Arizona, California, Florida, Georgia, Hawaii (Longs Drugs stores), Illinois, Iowa, Kansas, Maryland, Massachusetts, Missouri, New York, North Carolina, Pennsylvania, Rhode Island, Texas, Virginia and the District of Columbia.
  • MinuteClinic locations in Arizona, California, Connecticut, Florida, Georgia, Illinois, Indiana, Kansas, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Nevada, New Jersey, New York, North Carolina, Ohio, Oklahoma, Pennsylvania, South Carolina, Tennessee, Texas, Virginia and the District of Columbia.

The cost of the H1N1 flu vaccination shot at CVS/pharmacy and MinuteClinic is a $15 administration fee, which may be covered by insurance.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Giant Food launches free antibiotic prescription program

BY Antoinette Alexander

LANDOVER, Md. Giant Food is launching a free antibiotic prescription program that will run from Jan. 2 to March 21 in all Giant pharmacies.

The program covers 36 generic antibiotics in nine basic categories. The retailer is supporting the program with television ads, physician outreach, in-store communication and an expanded Web presence.

“Free antibiotics is the latest good news our pharmacies are offering the public,” stated Andrea Astrachan, consumer advisor for Giant Food. “We also offer up to a 90-day supply on over 350 commonly prescribed generic drugs for only $9.99.”

The company operates 182 supermarkets in Virginia, Maryland, Delaware and the District of Columbia. Within its 182 stores, 163 have full service pharmacies.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?